Suppr超能文献

口服减毒鸡伤寒沙门氏菌突变株作为禽伤寒活疫苗佐剂菌株,分泌大肠杆菌不耐热肠毒素 B 亚单位。

Oral immunization with an attenuated Salmonella Gallinarum mutant as a fowl typhoid vaccine with a live adjuvant strain secreting the B subunit of Escherichia coli heat-labile enterotoxin.

机构信息

College of Veterinary Medicine, Chonbuk National University, Jeonju 561-756, Republic of Korea.

出版信息

BMC Vet Res. 2013 May 6;9:96. doi: 10.1186/1746-6148-9-96.

Abstract

BACKGROUND

The Salmonella Gallinarum (SG) lon/cpxR deletion mutant JOL916 was developed as a live vaccine candidate for fowl typhoid (FT), and a SG mutant secreting an Escherichia coli heat-labile enterotoxin B subunit (LTB), designated JOL1229, was recently constructed as an adjuvant strain for oral vaccination against FT. In this study, we evaluated the immunogenicity and protective properties of the SG mutant JOL916 and the LTB adjuvant strain JOL1229 in order to establish a prime and boost immunization strategy for each strain. In addition, we compared the increase in body weight, the immunogenicity, the egg production rates, and the bacteriological egg contamination of these strains with those of SG 9R, a widely used commercial vaccine.

RESULTS

Plasma IgG, intestinal secretory IgA (sIgA), and cell-mediated responses were significantly induced after a boost inoculation with a mixture of JOL916 and JOL1229, and significant reductions in the mortality of chickens challenged with a wild-type SG strain were observed in the immunized groups. There were no significant differences in increases in body weight, cell-mediated immune responses, or systemic IgG responses between our vaccine mixture and the SG 9R vaccine groups. However, there was a significant elevation in intestinal sIgA in chickens immunized with our mixture at 3 weeks post-prime-immunization and at 3 weeks post-boost-immunization, while sIgA levels in SG 9R-immunized chickens were not significantly elevated compared to the control. In addition, the SG strain was not detected in the eggs of chickens immunized with our mixture.

CONCLUSION

Our results suggest that immunization with the LTB-adjuvant strain JOL1229 can significantly increase the immune response, and provide efficient protection against FT with no side effects on body weight, egg production, or egg contamination.

摘要

背景

鸡白痢沙门氏菌(SG)lon/cpxR 缺失突变株 JOL916 被开发为禽伤寒(FT)的活疫苗候选株,最近构建了一株分泌大肠杆菌不耐热肠毒素 B 亚单位(LTB)的 SG 突变株 JOL1229,作为口服接种 FT 的佐剂株。本研究评估了 SG 突变株 JOL916 和 LTB 佐剂株 JOL1229 的免疫原性和保护特性,以期建立这两种株系的初免-加强免疫策略。此外,我们比较了这些株系在体重增加、免疫原性、产蛋率和细菌污染率方面与广泛应用的商业疫苗 SG9R 的差异。

结果

初免-加强免疫混合接种 JOL916 和 JOL1229 后,鸡血浆 IgG、肠道分泌型 IgA(sIgA)和细胞介导的反应显著增强,免疫组鸡对野生型 SG 株的攻毒死亡率显著降低。与 SG9R 疫苗组相比,我们的疫苗混合物在体重增加、细胞介导免疫反应或全身 IgG 反应方面没有显著差异。然而,在初免后 3 周和加强免疫后 3 周,与对照组相比,混合免疫组鸡的肠道 sIgA 显著升高,而 SG9R 免疫组鸡的 sIgA 水平没有显著升高。此外,混合免疫组鸡的鸡蛋中未检测到 SG 株。

结论

我们的结果表明,用 LTB 佐剂株 JOL1229 免疫可以显著增强免疫反应,对 FT 提供高效保护,且对体重、产蛋率或鸡蛋污染无副作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/059d/3653815/f170a23d9e8d/1746-6148-9-96-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验